Effects of adenosine on lymphangiogenesis

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Lenoir, Bénédicte ^a   Wagner, Daniel R ^a,b   Blacher, Silvia ^c   Sala Newby, Graciela B ^d   Newby, Andrew C ^d   Noel, Agnès ^c   Devaux, Yvan ^a  

^a LUXEMBOURG INSTITUTE OF HEALTH   (Luxembourg)

^b CENTRE HOSPITALIER DE LUXEMBOURG   (Luxembourg)

^c UNIVERSITY OF LIÈGE   (Belgium)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 CHLOROADENOSINE; 5' ENDONUCLEOTIDASE; ADENOSINE; ADENOSINE RECEPTOR; ADENOVIRUS VECTOR; GELATIN SPONGE; NUCLEOTIDASE; UNCLASSIFIED DRUG;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CULTURE MEDIUM; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LYMPH VESSEL ENDOTHELIUM; LYMPHANGIOGENESIS; MACROPHAGE; MALE; MOUSE; NONHUMAN;

5'-NUCLEOTIDASE; ADENOSINE; ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CULTURE MEDIA, CONDITIONED; ENDOTHELIAL CELLS; GENE EXPRESSION; HUMANS; LIVER; LYMPHANGIOGENESIS; MACROPHAGES; MALE; MICE; RECEPTORS, PURINERGIC P1;

EID: 84898651933     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0092715     Document Type: Article

References (44)

1. Tammela T, Alitalo K (2010) Lymphangiogenesis: Molecular mechanisms and future promise. Cell 140: 460-476.
2. Karpanen T, Alitalo K (2008) Molecular biology and pathology of lymphangiogenesis. Annu Rev Pathol 3: 367-397. (Pubitemid 351488286)
3. Eklund L, Bry M, Alitalo K (2013) Mouse models for studying angiogenesis and lymphangiogenesis in cancer. Molecular Oncology 7: 259-282.
4. Alitalo K (2011) The lymphatic vasculature in disease. Nat Med 17: 1371-1380.
5. Alitalo A, Detmar M (2012) Interaction of tumor cells and lymphatic vessels in cancer progression. Oncogene 31: 4499-4508.
6. Paupert J, Sounni NE, Noel A (2011) Lymphangiogenesis in post-natal tissue remodeling: lymphatic endothelial cell connection with its environment. Mol Aspects Med 32: 146-158.
7. Flister MJ, Wilber A, Hall KL, Iwata C, Miyazono K, et al. (2010) Inflammation induces lymphangiogenesis through up-regulation of VEGFR-3 mediated by NF-kappaB and Prox1. Blood 115: 418-429.
8. Utrera-Barillas D, Castro-Manrreza M, Castellanos E, Gutierrez-Rodriguez M, Arciniega-Ruiz de Esparza O, et al. (2010) The role of macrophages and mast cells in lymphangiogenesis and angiogenesis in cervical carcinogenesis. Exp Mol Pathol 89: 190-196.
9. Detry B, Blacher S, Erpicum C, Paupert J, Maertens L, et al. (2013) Sunitinib inhibits inflammatory corneal lymphangiogenesis. Invest Ophthalmol Vis Sci 54: 3082-3093.
10. Harvey NL, Gordon EJ (2012) Deciphering the roles of macrophages in developmental and inflammation stimulated lymphangiogenesis. Vasc Cell 4: 15.
11. Ran S, Montgomery KE (2012) Macrophage-Mediated Lymphangiogenesis: The Emerging Role of Macrophages as Lymphatic Endothelial Progenitors. Cancers (Basel) 4: 618-657.
12. Kataru RP, Jung K, Jang C, Yang H, Schwendener RA, et al. (2009) Critical role of CD11b+ macrophages and VEGF in inflammatory lymphangiogenesis, antigen clearance, and inflammation resolution. Blood 113: 5650-5659.
13. Kelley PM, Connor AL, Tempero RM (2013) Lymphatic vessel memory stimulated by recurrent inflammation. Am J Pathol 182: 2418-2428.
14. Norrmen C, Tammela T, Petrova TV, Alitalo K (2011) Biological basis of therapeutic lymphangiogenesis. Circulation 123: 1335-1351.
15. Tammela T, Zarkada G, Wallgard E, Murtomaki A, Suchting S, et al. (2008) Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation. Nature 454: 656-660.
16. Antonioli L, Blandizzi C, Pacher P, Hasko G (2013) Immunity, inflammation and cancer: a leading role for adenosine. Nat Rev Cancer 13: 842-857.
17. Ernens I, Leonard F, Vausort M, Rolland-Turner M, Devaux Y, et al. (2010) Adenosine up-regulates vascular endothelial growth factor in human macrophages. Biochem Biophys Res Commun 392: 351-356.
18. Leonard F, Devaux Y, Vausort M, Ernens I, Rolland-Turner M, et al. (2011) Adenosine modifies the balance between membrane and soluble forms of Flt-1. J Leukoc Biol 90: 199-204.
19. Azuaje F, Leonard F, Rolland-Turner M, Devaux Y, Wagner DR (2011) Proof-of-principle investigation of an algorithmic model of adenosine-mediated angiogenesis. Theor Biol Med Model 8: 7.
20. Auchampach JA (2007) Adenosine receptors and angiogenesis. Circ Res 101: 1075-1077.
21. Feoktistov I, Biaggioni I, Cronstein BN (2009) Adenosine receptors in wound healing, fibrosis and angiogenesis. Handb Exp Pharmacol: 383-397.
22. Goblyos A, Ijzerman AP (2009) Allosteric modulation of adenosine receptors. Purinergic Signal 5: 51-61.
23. Jacobson KA, Gao ZG (2006) Adenosine receptors as therapeutic targets. Nat Rev Drug Discov 5: 247-264. (Pubitemid 43336037)
24. Bruyere F, Noel A (2010) Lymphangiogenesis: in vitro and in vivo models. Faseb J 24: 8-21.
25. Sala-Newby GB, Freeman NV, Curto MA, Newby AC (2003) Metabolic and functional consequences of cytosolic 5′-nucleotidase-IA overexpression in neonatal rat cardiomyocytes. Am J Physiol Heart Circ Physiol 285: H991-998. (Pubitemid 37048152)
26. Sala-Newby GB, Skladanowski AC, Newby AC (1999) The mechanism of adenosine formation in cells. Cloning of cytosolic 5′-nucleotidase-I. J Biol Chem 274: 17789-17793.
27. Ernens I, Rouy D, Velot E, Devaux Y, Wagner DR (2006) Adenosine inhibits matrix metalloproteinase-9 secretion by neutrophils: implication of A2A receptor and cAMP/PKA/Ca2+ pathway. Circ Res 99: 590-597. (Pubitemid 44401450)
28. Rolland-Turner M, Goretti E, Bousquenaud M, Leonard F, Nicolas C, et al. (2013) Adenosine stimulates the migration of human endothelial progenitor cells. Role of CXCR4 and microRNA-150. PLoS ONE 8: e54135.
29. Velot E, Haas B, Leonard F, Ernens I, Rolland-Turner M, et al. (2008) Activation of the adenosine-A3 receptor stimulates matrix metalloproteinase-9 secretion by macrophages. Cardiovasc Res 80: 246-254.
30. Ji RC (2012) Macrophages are important mediators of either tumor- or inflammation-induced lymphangiogenesis. Cell Mol Life Sci 69: 897-914.
31. Hasko G, Pacher P (2012) Regulation of macrophage function by adenosine. Arterioscler Thromb Vasc Biol 32: 865-869.
32. Kumar V (2013) Adenosine as an endogenous immunoregulator in cancer pathogenesis: where to go? Purinergic Signal 9: 145-165.
33. Ferrante CJ, Pinhal-Enfield G, Elson G, Cronstein BN, Hasko G, et al. (2013) The adenosine-dependent angiogenic switch of macrophages to an M2-like phenotype is independent of interleukin-4 receptor alpha (IL-4Ralpha) signaling. Inflammation 36: 921-931.
34. Olah ME, Caldwell CC (2003) Adenosine receptors and mammalian toll-like receptors: synergism in macrophages. Mol Interv 3: 370-374.
35. Pinhal-Enfield G, Ramanathan M, Hasko G, Vogel SN, Salzman AL, et al. (2003) An angiogenic switch in macrophages involving synergy between Toll-like receptors 2, 4, 7, and 9 and adenosine A(2A) receptors. Am J Pathol 163: 711-721. (Pubitemid 36909432)
36. Ramanathan M, Luo W, Csoka B, Hasko G, Lukashev D, et al. (2009) Differential regulation of HIF-1{alpha} isoforms in murine macrophages by TLR4 and adenosine A2A receptor agonists. J Leukoc Biol 86: 681-689.
37. Avraham-Davidi I, Yona S, Grunewald M, Landsman L, Cochain C, et al. (2013) On-site education of VEGF-recruited monocytes improves their performance as angiogenic and arteriogenic accessory cells. The Journal of Experimental Medicine 210: 2611-2625.
38. Martin C, Leone M, Viviand X, Ayem ML, Guieu R (2000) High adenosine plasma concentration as a prognostic index for outcome in patients with septic shock. Crit Care Med 28: 3198-3202.
39. Sperlagh B, Doda M, Baranyi M, Hasko G (2000) Ischemic-like condition releases norepinephrine and purines from different sources in superfused rat spleen strips. J Neuroimmunol 111: 45-54.
40. Blay J, White TD, Hoskin DW (1997) The extracellular fluid of solid carcinomas contains immunosuppressive concentrations of adenosine. Cancer Res 57: 2602-2605. (Pubitemid 27283766)
41. Cekic C, Sag D, Li Y, Theodorescu D, Strieter RM, et al. (2012) Adenosine A2B Receptor Blockade Slows Growth of Bladder and Breast Tumors. The Journal of Immunology 188: 198-205.
42. Chung C, Iwakiri Y (2013) The lymphatic vascular system in liver diseases: its role in ascites formation. Clin Mol Hepatol 19: 99-104.
43. Chiang DJ, Roychowdhury S, Bush K, McMullen MR, Pisano S, et al. (2013) Adenosine 2A Receptor Antagonist Prevented and Reversed Liver Fibrosis in a Mouse Model of Ethanol-Exacerbated Liver Fibrosis. PLoS ONE 8: e69114.
44. Hocher B, Heiden S, von Websky K, Arafat AM, Rahnenfuhrer J, et al. (2011) Renal effects of the novel selective adenosine A1 receptor blocker SLV329 in experimental liver cirrhosis in rats. PLoS One 6: e17891.